Rufinamide for Refractory Focal Seizures: An Open-Label, Multicenter European Study

Seizure : the journal of the British Epilepsy Association - United Kingdom
doi 10.1016/j.seizure.2012.09.015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Safety and Tolerability of Adjunctive Lacosamide in a Pediatric Population With Focal Seizures-An Open-Label Trial

Seizure : the journal of the British Epilepsy Association
MedicineNeurology
2019English

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2018English

Mycophenolate Mofetil for Myasthenia Gravis: An Open-Label Pilot Study

Neurology
Neurology
2001English

Umbralisib Monotherapy Demonstrates Efficacy and Safety in Patients With Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter, Open-Label, Registration Directed Phase 2 Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Cannabidiol Improves Frequency and Severity of Seizures and Reduces Adverse Events in an Open-Label Add-On Prospective Study

Epilepsy and Behavior
NeurologyBehavioral Neuroscience
2018English

Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study

OncoTargets and Therapy
OncologyPharmacology
2019English

Tolerability and Safety of Novel Half Milliliter Formulation of Glatiramer Acetate for Subcutaneous Injection: An Open-Label, Multicenter, Randomized Comparative Study

Journal of Neurology
Neurology
2010English

Evaluating Dose Regimens of Apomorphine, an Open-Label Study

International Journal of Impotence Research
Urology
2003English

An Open-Label, Prospective Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Long-Term Treatment of Refractory Depression

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy